Ramiprilat

CAS: 87269-97-4

Ref. 3D-FR27678

Información del producto

• Nombre: Ramiprilat
• Sinónimos: (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid, (2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-Carboxy-3-phenylpropyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (non-preferred name), Cyclopenta[b]pyrrole-2-carboxylic acid, 1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]-1-oxopropyl]octahydro-, (2S,3aS,6aS)-, Cyclopenta[b]pyrrole-2-carboxylic acid, 1-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]octahydro-, [2S-[1[R*(R*)],2α,3aβ,6aβ]]-, HOE 498 diacid, Ramipril diacid, Ramiprilate

Descripción

Ramiprilat is an angiotensin-converting enzyme inhibitor that is used to treat high blood pressure and congestive heart failure. It binds to the active site of the enzyme and blocks its activity, inhibiting the formation of angiotensin II. Ramiprilat reduces matrix metalloproteinase (MMP)-9 activity in human polymorphonuclear leukocytes, which may be due to its inhibitory properties on MMP-9 synthesis. This drug has been shown to decrease the rate of myocardial infarction in patients with left ventricular dysfunction.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 388.46 g/mol
• Fórmula: C₂₁H₂₈N₂O₅
• Pureza: Min. 97 Area-%
• Color/Forma: Powder